Mon, 15th Jun 2020 12:58
Yourgene Health PLC - Manchester-based molecular diagnostics company - Receives CE-IVD marking for Illumina-based IONA non-invasive prenatal test for Down's syndrome and other genetic disorders. New test IONA Nx to be launched across EU and UK as well as other countries that accept the CE-IVD mark in coming months.
Current stock price: 18.45 pence
Year-to-date change: up 39%
By Ife Taiwo; ifetaiwo@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
(Alliance News) - Yourgene Health PLC on Friday announced that its takeover by Novacyt SA, a biotechnology group focused on clinical diagnostics, is c...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
(Alliance News) - FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series.
Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by...
